Migraine Headache Differential Diagnosis for Patients

Migraine, Occipital Neuralgia, or Cervicogenic Headache? Why the Correct Diagnosis Matters Before BOTOX

Pain at the back of the head can be confusing. Three people may point to almost the same place—the base of the skull—and yet have three different conditions that require three different clinical approaches.

One person may have chronic migraine, a neurological headache disorder that can qualify for preventive BOTOX® (onabotulinumtoxinA) treatment when specific criteria are met. Another may have occipital neuralgia, in which irritated occipital nerves create sharp or electric pain through the back of the scalp. A third may have a cervicogenic headache, meaning the headache is being referred from a disorder or painful structure in the cervical spine or surrounding neck tissues.

That distinction matters.

Pain location alone cannot tell a clinician which diagnosis is correct. Neck pain can occur during a migraine. Occipital neuralgia can radiate toward the forehead. Cervicogenic headache can resemble migraine and may even include light or sound sensitivity. Recent clinical literature continues to emphasize the substantial overlap among migraine, occipital neuralgia, and cervicogenic headache and the importance of distinguishing them before choosing treatment (Kissoon et al., 2025).

Most importantly, FDA approval of BOTOX for chronic migraine should not be interpreted as FDA approval of BOTOX for every headache involving the forehead, temples, neck, or back of the head.

Three Patients, One Pain Location, Three Different Stories

Imagine three hypothetical patients arriving at an El Paso headache and musculoskeletal clinic on the same morning.

All three say:

“My pain starts near the back of my head.”

Their stories quickly begin to separate.

Patient One: Maria and the Headaches That Take Over Her Month

Maria is 42. She reports headaches on 18 to 20 days during a typical month. On many of those days, the pain lasts six hours or longer.

Several attacks are throbbing and moderately to severely painful. Routine activity can make them worse. During the more intense episodes, Maria wants to lie in a dark room because light and sound become difficult to tolerate. She sometimes feels nauseated.

She also has neck tightness.

That last symptom could easily send the evaluation in the wrong direction.

Neck discomfort does not automatically mean the headache originates in the cervical spine. Neck pain and stiffness can occur as part of migraine itself. The International Classification of Headache Disorders, Third Edition (ICHD-3) describes migraine without aura as recurrent attacks commonly involving moderate-to-severe pain, pulsating quality, worsening with normal physical activity, nausea, and/or sensitivity to light and sound (Headache Classification Committee of the International Headache Society [IHS], 2018).

When headaches become extremely frequent, the clinician evaluates for chronic migraine.

ICHD-3 defines chronic migraine as headache occurring on 15 or more days per month for more than three months, with migraine features present on at least eight days per month, subject to the complete diagnostic criteria and exclusion of a better explanation (IHS, 2018).

Maria’s history therefore warrants a structured migraine assessment rather than assuming that pain behind the head must be a neck or nerve problem.

A headache diary can be particularly valuable. Patients can record headache days, duration, migraine features, medication use, menstrual or hormonal patterns, sleep changes, possible triggers, associated neck symptoms, and functional impairment.

Dr. Jimenez discusses this broader diagnostic approach in his educational material on headache and migraine diagnosis and migraine treatment options.

When BOTOX May Enter the Chronic Migraine Conversation

BOTOX is a prescription form of onabotulinumtoxinA.

Its FDA-approved migraine indication is specific: BOTOX is indicated for the prevention, or prophylaxis, of headaches in adults with chronic migraine who have 15 or more headache days per month, with headaches lasting four hours a day or longer. The prescribing information also states that safety and effectiveness have not been established for preventing episodic migraine involving 14 or fewer headache days per month.

For the approved chronic migraine protocol, the recommended treatment uses 155 units divided among 31 injection sites across seven specific head and neck muscle areas, with a recommended retreatment schedule of every 12 weeks. Treatment is preventive. It is intended to reduce future headache burden rather than act as an immediate rescue treatment for a migraine already underway.

This is why diagnosis comes first.

A person does not become an appropriate chronic migraine BOTOX candidate simply because:

• the headache is severe
• the pain occurs behind the head
• neck muscles feel tight
• headaches occur after stress
• another person with headaches improved with BOTOX, or
• cosmetic BOTOX helped facial muscle tension.

The clinician must establish the headache diagnosis, frequency, duration, associated features, medical history, previous treatments, contraindications, and other relevant clinical factors.

Patient Two: David and the Sudden Electrical Shock

David is 38. His problem sounds very different.

He describes brief bursts of intense pain beginning near the upper neck and shooting across the back of his scalp.

“It’s like somebody touches a live wire,” he says.

The attacks may last seconds or minutes. Between episodes, the skin at the back of his head remains unusually sensitive. Brushing his hair sometimes hurts. An examination reveals distinct tenderness along the path of the greater occipital nerve.

Occipital neuralgia is now an important part of the differential diagnosis.

What Occipital Neuralgia Feels Like

The greater, lesser, and third occipital nerves provide sensation to portions of the posterior scalp. Irritation or dysfunction involving these nerves may produce a characteristic neuralgic pain pattern.

ICHD-3 describes occipital neuralgia as unilateral or bilateral pain involving the distribution of these nerves. Typical pain is:

• shooting, stabbing, or sharp;
• severe;
• recurrent in attacks lasting seconds to minutes;
• associated with scalp sensitivity, abnormal sensation, or pain from normally harmless touch; and
• associated with tenderness or trigger points along the involved nerve distribution.

Temporary improvement after an appropriate local anesthetic nerve block is also part of the formal diagnostic criteria (IHS, 2018).

Dr. Jimenez’s educational resource on occipital neuralgia similarly discusses how pain can begin near the base of the skull and travel over the scalp, sometimes creating symptoms that patients initially believe are migraine.

Why Occipital Neuralgia Can Be Mistaken for Migraine

Human pain pathways do not follow simple lines on a diagram.

Occipital nerve pain can extend forward through connections between upper cervical sensory pathways and the trigeminal system. A person with occipital neuralgia may therefore experience pain extending toward the forehead or around the eye. At the same time, people with migraine can experience pain in the occipital region and significant neck discomfort.

The two disorders can also coexist.

A 2026 systematic review found that migraine was a frequent coexisting condition among patients with occipital neuralgia, demonstrating why clinicians should not assume that every patient has only one headache disorder.

History and examination therefore matter more than simply asking, “Where does it hurt?”

Does the Chronic Migraine BOTOX Approval Include Occipital Neuralgia?

No.

The FDA-approved chronic migraine indication does not establish BOTOX as an FDA-approved treatment for occipital neuralgia.

Published literature has explored botulinum toxin in occipital neuralgia, but the evidence base and clinical context are different from the established chronic migraine indication. Reviews have noted that additional research is needed to determine its effectiveness and safety for occipital neuralgia (Urits et al., 2021; Swanson et al., 2022).

A clinician may sometimes discuss therapies used outside a product’s FDA-approved indication when medically appropriate. That is a separate off-label clinical decision, not an extension of the FDA’s chronic migraine approval. It should involve individualized assessment, consideration of available evidence, risks and benefits, and informed patient consent.

For David, therefore, the first question is not, “Where should we inject BOTOX?”

The first question is, “What is generating this electrical occipital pain?”

Patient Three: Elena and the Headache That Moves With Her Neck

Elena is 51. Months earlier, she injured her neck.

Her headaches frequently start around the upper neck and back of the skull before spreading toward one side of her head. Unlike Maria’s migraine attacks, Elena notices something especially consistent: turning her head or maintaining certain neck positions can reproduce the familiar headache.

Her neck mobility is limited.

Pressing specific upper cervical structures may provoke pain resembling the headache she experiences at home.

This raises another possibility:

Cervicogenic headache.

What Is a Cervicogenic Headache?

A cervicogenic headache is considered a secondary headache because another disorder—specifically a cervical spine or neck disorder—causes the head pain.

ICHD-3 describes it as a headache caused by a disorder involving the cervical spine and its bony, disc, or soft-tissue components, with or without accompanying neck pain (IHS, 2018).

Evidence connecting the neck disorder to the headache may include factors such as:

• the headache developing in temporal relationship to the cervical problem;
• headache improving as the cervical disorder improves;
• reduced cervical range of motion;
• significant worsening of the familiar headache with appropriate neck-provoking maneuvers; or
• headache being abolished after a diagnostic block of an implicated cervical structure or its nerve supply.

Imaging can assist the evaluation in selected patients, but an abnormal MRI or X-ray does not automatically prove causation. ICHD-3 specifically cautions that cervical imaging abnormalities are common even among people without headaches.

Dr. Jimenez further discusses the relationship between neck disorders and referred head pain in Cervicogenic Headaches Associated With Neck Issues and his overview of cervicogenic headache triggers.

Neck Pain Does Not Automatically Equal Cervicogenic Headache

This is one of the most important lessons in headache differential diagnosis.

Many people with migraine report neck pain.

Occipital neuralgia can involve the upper neck.

Cervicogenic headache originates from the neck.

Those statements may sound similar, but clinically they mean different things.

Features that can support cervicogenic headache include side-locked pain, reduced cervical mobility, reproduction of the familiar headache with cervical movement or pressure, and pain that travels from the back of the head toward the front. However, none of these features should be interpreted in isolation, and some patients with cervicogenic headache can experience migraine-like symptoms such as nausea or light sensitivity.

Treatment should therefore address the established diagnosis rather than the pain location alone.

For appropriately diagnosed cervicogenic headache, rehabilitation may include individualized exercise, movement restoration, manual therapy, posture and ergonomic strategies, and other conservative interventions when clinically appropriate. Evidence suggests manual therapy may provide short-term benefit for some adults with cervicogenic headache, although the certainty and durability of effects vary among studies (Núñez-Cabaleiro & Leirós-Rodríguez, 2022; Varatharajan et al., 2026).

Why Diagnostic Accuracy Matters Before BOTOX

Returning to our three hypothetical patients makes the difference clear.

Maria may have chronic migraine and could warrant evaluation for an FDA-approved preventive BOTOX protocol.

David demonstrates characteristics suggesting occipital neuralgia, requiring evaluation of an occipital nerve pain generator and consideration of an entirely different diagnostic pathway.

Elena demonstrates mechanical cervical findings that raise concern for cervicogenic headache, meaning the cervical source itself needs careful evaluation.

All three patients hurt near the back of the head.

Yet treating all three according to the same diagnosis could miss the actual problem.

The International Headache Society specifically reminds clinicians that a headache diagnosis should not be accepted when another disorder better explains the presentation. Differential diagnosis is therefore not an unnecessary obstacle before treatment. It is part of responsible headache care.

A Headache Evaluation Looks Beyond One Symptom

A careful evaluation may explore:

• number of headache days per month;
• number of days with migraine features;
• typical duration of untreated or unsuccessfully treated attacks;
• location and quality of pain;
• nausea or vomiting;
• light and sound sensitivity;
• aura symptoms;
• scalp tenderness or allodynia;
• electrical, stabbing, burning, or shock-like pain;
• cervical range of motion;
• whether neck movement reproduces the headache;
• previous neck or head trauma;
• medication use and possible medication-overuse headache;
• neurological symptoms;
• prior preventive and acute treatments;
• sleep, hormonal, metabolic, and lifestyle factors; and
• findings suggesting that imaging, laboratory testing, specialty referral, or another diagnostic procedure is needed.

A headache diary can help transform “I have headaches all the time” into clinically useful information.

Some Headaches Need Urgent Evaluation

Patients should not automatically assume a new or dramatically different headache is migraine, occipital neuralgia, or a neck problem.

Urgent medical evaluation may be necessary for a sudden explosive or “worst-ever” headache, new weakness or numbness, difficulty speaking, confusion, fainting, seizure, fever with severe headache or neck stiffness, significant recent head trauma, or other rapidly developing neurological symptoms.

A major change from a person’s established headache pattern also deserves medical attention.

The goal of differential diagnosis is not merely to assign a name to pain. It is also to ensure more serious causes are not overlooked.

The Injury Medical Chiropractic and Functional Medicine Clinic Approach

At Dr. Jimenez’s Injury Medical Chiropractic and Functional Medicine Clinic in El Paso, headache care benefits from a multidisciplinary structure rather than viewing every headache solely as a neurological, muscular, or spinal problem.

Dr. Alex Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, combines his training as a Doctor of Chiropractic and board-certified Family Nurse Practitioner with experience evaluating musculoskeletal and soft-tissue injuries, spinal biomechanics, neurological complaints, rehabilitation needs, and broader medical factors. The clinic works alongside Dr. Maria Guadalupe Cardenas, MD, a board-certified internal medicine physician who serves as medical director and collaborative physician.

That structure can be especially useful when headache symptoms overlap. A patient may need assessment of migraine criteria while also having cervical dysfunction, a history of whiplash, occipital nerve tenderness, metabolic concerns, sleep disruption, or another contributor requiring evaluation.

When chronic migraine criteria and the complete medical evaluation support treatment, BOTOX may become part of a medically directed preventive strategy. When the evidence points instead to cervicogenic headache, occipital neuralgia, or another condition, the treatment pathway can change accordingly.

This multidisciplinary approach supports an important principle:

The procedure should follow the diagnosis—not the other way around.

BOTOX Is a Chronic Migraine Treatment, Not a Universal Headache Injection

BOTOX has an established and important role in chronic migraine prevention.

But its FDA approval has boundaries.

It does not mean that every recurring headache should receive BOTOX. It does not turn pain at the base of the skull into chronic migraine. And it does not remove the need to distinguish neurological migraine mechanisms from occipital nerve pain or cervical referred pain.

For a patient considering BOTOX, perhaps the most useful first question is therefore not:

“Can BOTOX help my headache?”

A better question is:

“What type of headache do I actually have?”

Once that question is answered carefully, patients and their healthcare professionals can make a much more informed decision about whether chronic migraine prevention, neurological treatment, cervical rehabilitation, nerve-focused care, or another medical pathway makes the most sense.

That is the value of an accurate diagnosis: not simply giving the pain a label, but helping the patient receive the treatment that fits the condition.

---

References

AbbVie Inc. (2024). BOTOX® (onabotulinumtoxinA) prescribing information. BOTOX Prescribing Information

American Headache Society. (2026). Pharmacologic treatment for migraine prevention in adults practice guideline recommendations. American Headache Society clinical practice guidelines

Headache Classification Committee of the International Headache Society. (2018). The International Classification of Headache Disorders, 3rd edition. Cephalalgia, 38(1), 1–211. International Classification of Headache Disorders, 3rd Edition

Kissoon, N. R., et al. (2025). A pain in the neck: Occipital neuralgia vs. cervicogenic headache vs. migrainous cervicalgia. Current Pain and Headache Reports. PubMed record

Núñez-Cabaleiro, P., & Leirós-Rodríguez, R. (2022). Effectiveness of manual therapy in the treatment of cervicogenic headache: A systematic review. Headache, 62(3), 271–283. PubMed record

Swanson, D., et al. (2022). An update on the diagnosis, treatment, and management of occipital neuralgia. Journal of Craniofacial Surgery. PubMed record

Urits, I., et al. (2021). Occipital neuralgia. Current Pain and Headache Reports. PubMed record

Varatharajan, S., et al. (2026). Efficacy of nonsurgical interventions for the management of adults with cervicogenic headache: A systematic review and meta-analyses. PubMed record